GAMMA BUTYROLACTONE (GBL): Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Gamma butyrolactone (GBL) is a chemical in cleaning solutions and nail polish. In the body, GBL is converted to gamma-hydroxybutyrate (GHB), a date-rape drug.

When the body converts GBL into GHB, it can turn off some functions of the nervous system.

Despite serious safety concerns, people use GBL as a party drug, for athletic performance, depression, and other purposes, but there is no good scientific evidence to support these uses.

GBL is classified as a Schedule I controlled substance, making it illegal in the US. Don't confuse GBL with Gamma-hydroxybutyrate (GHB) or 1,4-Butanediol. These chemicals are related but are not the same.

Uses & Effectiveness

We currently have no information for GAMMA BUTYROLACTONE (GBL) overview.

Side Effects

When taken by mouth: GBL is unsafe. It can cause very serious side effects, including seizures, coma, and death.

Special Precautions and Warnings

When taken by mouth: GBL is unsafe. It can cause very serious side effects, including seizures, coma, and death.

Pregnancy and breast-feeding: GBL is unsafe for anyone when taken by mouth, including those who are pregnant and breast-feeding. Avoid use.

Slow heart rate: GBL can make this condition worse. Avoid use.

Seizure disorder (epilepsy): GBL might cause seizures. Avoid use.

Surgery: GBL can affect the central nervous system (CNS). It might cause too much sleepiness if it is used along with anesthesia and other medications during and after surgery. GBL should not be used in the two weeks before a scheduled surgery.

A rare disorder called succinic semialdehyde dehydrogenase deficiency: People with this condition are at a greater risk for serious adverse reactions from GBL. Avoid use.

Interactions

Moderate Interaction

Be cautious with this combination

Alcohol (Ethanol) interacts with GAMMA BUTYROLACTONE (GBL)
Alcohol can cause sleepiness and drowsiness. Taking GBL along with alcohol might greatly increase sleepiness and drowsiness caused by alcohol and lead to serious side effects. Do not take GBL if you have been drinking.
Amphetamines interacts with GAMMA BUTYROLACTONE (GBL)
Amphetamines are drugs that can speed up the nervous system. GBL is changed in the body to gamma-hydroxybutyrate (GHB). GHB can slow down the nervous system. Taking GBL along with amphetamines can lead to serious side effects.
Medications for pain (Narcotic drugs) interacts with GAMMA BUTYROLACTONE (GBL)
Some medications for pain can cause sleepiness and drowsiness. GBL might also cause sleepiness and drowsiness. Taking GBL along with some medications for pain might cause severe side effects. Do not take GBL if you are taking medications for pain.
Medications used to prevent seizures (Anticonvulsants) interacts with GAMMA BUTYROLACTONE (GBL)
GBL may increase the risk of seizures. Therefore, taking GBL may decrease the effects of medications used to prevent seizures. This might increase the risk of seizures.
Naloxone (Narcan) interacts with GAMMA BUTYROLACTONE (GBL)
GBL is changed by the body to another chemical that can affect the brain. Taking naloxone along with GBL might decrease the effects of naloxone.
Ritonavir (Norvir) interacts with GAMMA BUTYROLACTONE (GBL)
Taking ritonavir with GBL might decrease how quickly the body gets rid of GBL. This could increase the effects of GBL and cause serious side effects.
Saquinavir (Fortovase, Invirase) interacts with GAMMA BUTYROLACTONE (GBL)
Taking saquinavir with GBL might decrease how fast the body gets rid of GBL. This could increase the effects of GBL and cause serious side effects.
Sedative medications (CNS depressants) interacts with GAMMA BUTYROLACTONE (GBL)
GBL might cause sleepiness and slowed breathing. Some medications, called sedatives, can also cause sleepiness and slowed breathing. Taking GBL with sedative medications might cause breathing problems and/or too much sleepiness.
Divalproex sodium (Depakote) interacts with GAMMA BUTYROLACTONE (GBL)
Taking divalproex sodium at the same time as GBL might decrease how quickly the body gets rid of GBL. This could cause serious side effects.
Topiramate (Topamax) interacts with GAMMA BUTYROLACTONE (GBL)
Taking topiramate plus GBL might decrease how quickly the body gets rid of GBL. This could cause serious side effects.

Dosing

Although it is illegal in the US, GBL has been used as a party and date-rape drug. GBL is unsafe. Any use runs the risk of serious side effects, including seizures, coma, and death.

View References

REFERENCES:

Anon. Adverse events associated with ingestion of gamma-butyrolactone--Minnesota, New Mexico, and Texas, 1998-1999. MMWR Morb Mortal Wkly Rep 1999;48:137-40. View abstract.

Anon. FDA alert on misuse of consumer products containing GHB, GBL and BD. Food and Drug Administration, Rockville, MD. June 15, 1999.

Anon. Important message for health professionals: Report serious adverse events associated with dietary supplements containing GBL, GHB or BD. Food and Drug Administration, Rockville, MD. August 25, 1999. Available at: https://vm.cfsan.fda.gov/~dms/mwgblghb.html

Anon. Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate. JAMA 1991;265:447-8.

Bhattacharya IS, Watson F, Bruce M. A case of ?-butyrolactone associated with severe withdrawal delirium and acute renal failure. Eur Addict Res 2011;17(4):169-71. VIew abstract.

Bosch OG, Eisenegger C, Gertsch J, et al. Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone. Psychoneuroendocrinology. 2015 Dec;62:1-10. View abstract.

Carotenuto A, De Feo V, Fattorusso E, et al. The flavonoids of Allium ursinum. Phytochem 1996;41:531-6. View abstract.

Cash CD. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent (abstract). Neurosci Biobehav Rev 1994;18:291-304. View abstract.

Corkery JM, Loi B, Claridge H, et al. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neurosci Biobehav Rev 2015;53:52-78. View abstract.

Dargan PI, Button J, Davies S, et al. The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion. J R Soc Med 2009;102(12):546-7. View abstract.

Delcourt N, Lanot T, Vardon-Bounes F, Gandia P, Franchitto N. Severe metabolic failures after recreational ingestion of ?-butyrolactone. J Clin Psychopharmacol. 2020 Nov/Dec;40(6):624-626. View abstract.

Delic M. Inpatient management of GHB/GBL withdrawal. Psychiatr Danub. 2019 Sep;31(Suppl 3):354-356. View abstract.

Dougherty GG, Ellinwood EH Jr. Influence of gamma-butyrolactone on behavior due to dopaminergic drugs (abstract). Physiol Behav 1983;30:607-12. View abstract.

Eiden C, Capdevielle D, Deddouche C, et al. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal. J Addict Med 2011;5(4):302-3. View abstract.

Ellinwood EH Jr, Gonzalez AE, Dougherty GG Jr. Gamma-Butyrolactone effects on behavior induced by dopamine agonists (abstract). Biol Psychiatry 1983;18:1023-32. View abstract.

FDA Talk Paper. FDA Warns About GBL-Related Products. 1999. Available at: vm.cfsan.fda.gov/~lrd/tpgbl2.html

FDA. FDA warns about products containing gamma butyrolactone or GBL and asks companies to issue a recall. Talk Paper, 21 January 1999.

Feigenbaum JJ, Howard SG. Gamma hydroxybutyrate is not a GABA agonist (abstract). Prog Neurobiol 1996;50:1-7. View abstract.

Ferrara SD, Tedeschi L, Frison G, Rossi A. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. J Forensic Sci 1995;40:501-4. View abstract.

Harrington RD, Woodward JA, Hooton TM, et al. Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate. Arch Intern Med 1999;159:2221-4. View abstract.

Heytens L, Neels H, Van Regenmortel N, et al. Near-fatal persistent anion- and osmolal-gap acidosis due to massive gamma-butyrolactone/ethanol intoxication. Ann Clin Biochem 2015;52(Pt 2):283-7. View abstract.

Hillory J. Farias and Samantha Reid date-rape drug prohibition act of 2000. 106th Congress of the United States of America. HR 2130.

Kohrs FP, Porter WH, et al. Gamma-hydroxybutyrate intoxication and overdose. [Letter and responses]. Ann Emerg Med 1999;33:475-6.

LoVecchio F, Curry SC, Bagnasco T. Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a dietary supplement. N Engl J Med 1998;339:847-8.

Maitre M. The gamma-hydroxybutyrate signaling system in brain: organization and functional implications (abstract). Prog Neurobiol 1997;51:337-61. View abstract.

Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism (abstract). Neurosci Biobehav Rev 1989;13:187-98. View abstract.

Mason P, Kerns II W. Gamma Hydroxybutyric Acid (GHB) Intoxication. Acad Emerg Med 2002;9:730-39.. View abstract.

Product information for Xyrem. Jazz Pharmaceuticals, Inc. Palo Alto, CA. March 2022.

Roberts DM, Smith MW, Gopalakrishnan M, et al. Extreme ?-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis. Ann Emerg Med 2011;58(1):83-5. View abstract.

Schep LJ, Knudsen K, Slaughter RJ, et al. The clinical toxicology of ?-hydroxybutyrate, ?-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila) 2012;50(6):458-70. View abstract.

Schneir AB, Ly BT, Clark RF. A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol. J Emerg Med 2001;21:31-3.. View abstract.

Sivilotti ML, Burns MJ, Aaron CK, Greenberg MJ. Pentobarbital for severe gamma-butyrolactone withdrawal. Ann Emerg Med 2001;38:660-5.. View abstract.

Snead OC III, Bearden LJ. Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate (abstract). Neurol 1980;30:832-8. View abstract.

Soderling E, Le Bell A, Kirstila V, Tenovuo J. Betaine-containing toothpaste relieves subjective symptoms of dry mouth. Acta Odontol Scand 1998;56:65-9. View abstract.

Thai D, Dyer JE, Benowitz NL, Haller CA. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J Clin Psychopharmacol. 2006 Oct;26(5):524-9. View abstract.

Tunnicliff G. Significance of gamma-hydroxybutyric acid in the brain. Gen Pharmacol 1992;23:1027-34. View abstract.

Tunnicliff, G. Sites of action of gamma-hydroxybutyrate (GHB)-a neuroactive drug with abuse potential. J Toxicol Clin Toxicol 1997;35:581-90. View abstract.

Van Cauter E, Plat L, Scharf MB, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men (abstract). J Clin Invest 1997;100:745-53. View abstract.

van Gerwen M, Scheper H, Touw DJ, van Nieuwkoop C. Life-threatening acute lung injury after gamma butyrolactone ingestion. Neth J Med 2015;73(3):133-5. View abstract.

van Helmond LPFM, Gresnigt FMJ. Safety of withholding intubation in gamma-hydroxybutyrate- and gamma-butyrolactone-intoxicated coma patients in the emergency department. Eur J Emerg Med. 2020 Jun;27(3):223-227. View abstract.

Weiss T, Müller D, Marti I, Happold C, Russmann S. Gamma-hydroxybutyrate (GHB) and topiramate--clinically relevant drug interaction suggested by a case of coma and increased plasma GHB concentration. Eur J Clin Pharmacol. 2013 May;69(5):1193-4.View abstract.

Zepf FD, Holtmann M, Duketis E, et al. A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium. Pharmacopsychiatry 2009;42(5):202-3. View abstract.

Zvosec DL, Smith SW, McCutcheon JR, et al. Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med. 2001;344:87-94.. View abstract.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.

GAMMA BUTYROLACTONE (GBL) - Uses, Side Effects, and More

Overview

Uses & Effectiveness

Side Effects

Special Precautions and Warnings

Interactions

Moderate Interaction

Alcohol (Ethanol) interacts with GAMMA BUTYROLACTONE (GBL)

Amphetamines interacts with GAMMA BUTYROLACTONE (GBL)

Medications for pain (Narcotic drugs) interacts with GAMMA BUTYROLACTONE (GBL)

Medications used to prevent seizures (Anticonvulsants) interacts with GAMMA BUTYROLACTONE (GBL)

Naloxone (Narcan) interacts with GAMMA BUTYROLACTONE (GBL)

Ritonavir (Norvir) interacts with GAMMA BUTYROLACTONE (GBL)

Saquinavir (Fortovase, Invirase) interacts with GAMMA BUTYROLACTONE (GBL)

Sedative medications (CNS depressants) interacts with GAMMA BUTYROLACTONE (GBL)

Divalproex sodium (Depakote) interacts with GAMMA BUTYROLACTONE (GBL)

Topiramate (Topamax) interacts with GAMMA BUTYROLACTONE (GBL)

Dosing